The content on this page is intended for healthcare professionals. If you are a patient
researching testing options for a disease, we want you to remember that all health
information should be discussed with your doctor.
The
proprietary Ambry Test® combines scanning and sequencing technologies to analyze
a gene’s entire coding region plus surrounding critical introns. Capable of identifying
approximately 99% of all disease-causing mutations of the CFTR gene, the company’s
reputable Cystic Fibrosis test has an unrivaled detection rate across all ethnic
groups. The Company also created the world’s first and only comprehensive genetic
test for three principal genes (PRSS1, SPINK1 and CFTR) associated with Chronic
and Hereditary Pancreatitis. Ambry Genetics’ most recent developments focus on diagnosis
of pulmonary conditions, including Alpha-1-Antitrypsin Deficiency, Surfactant Protein
B Deficiency, Surfactant Protein C Deficiency, and ABCA3-Related Surfactant Deficiency.
Disclaimer:
This test was developed and its performance characteristics were determined by Ambry
Genetics Corporation. The laboratory is regulated under the Clinical Laboratory
Improvement Amendments 2003 as qualified to perform nonwaived testing. Although
molecular tests are highly accurate, rare diagnostic errors may occur. The Ambry
Test: Full Gene Analysis (FGA) analyzes the following types of mutations: nucleotide
substitutions, small deletions, small insertions, and small indels. In addition,
the Ambry Test: Gross Del/Dup analyzes the following types of mutations: gross insertions
and gross deletions. Both methods technically could miss gross rearrangement mutations
and other unknown abnormalities. The pattern of mutation types varies with the gene
tested and the Ambry Test detects a high but variable percentage of known and unknown
mutants of the classes stated. A negative result from the analysis cannot rule out
the possibility that the tested individual carries a rare unexamined mutation or
mutation in the undetectable group. A report does not represent medical advice.
Any questions, suggestions, or concerns regarding interpretation of results should
be forwarded to a genetic counselor, medical geneticist, or physician skilled in
interpretation of the relevant medical literature. References are available upon
request.









